Tag: adalimumab-ryvk

FDA approves biosimilar SIMLANDI by Alvotech and Teva Pharmaceuticals

businessnewstoday- February 25, 2024

Alvotech and Teva Pharmaceuticals have achieved a significant milestone with the U.S. Food and Drug Administration's (FDA) approval of SIMLANDI (adalimumab-ryvk) injection. This approval positions ... Read More